Biosplice Therapeutics vs Senda Biosciences

Biosplice Therapeutics

Restore health by delivering first-in-class therapies that harness alternative splicing

37 employees · est. 2008 · San Diego, United States

Senda Biosciences

Harnessing nature to program targeted, potent and tunable medicines

8 employees · est. 2017 · Cambridge, United States

Biosplice Therapeutics is the older company (2008 vs 2017); Biosplice Therapeutics is the larger of the two.

2 signals in the last 90 days

0 Biosplice Therapeutics

See the signals

2 Senda Biosciences

Open roles · Open role in a key function

latest 2 months ago See the signals

Side-by-Side Comparison

Metric	Biosplice Therapeutics	Senda Biosciences
Founded
Founded	2008 older	2017
Headquarters
Headquarters	San Diego, United States	Cambridge, United States
Employees
Employees	37 larger	8
Industry
Industry	Biotechnology, Health Care, Life Sciences	Biotechnology, Health Care, Life Sciences
Funding Stage
Funding Stage	Grant	Merged
Total Funding
Total Funding	$778.00M	$266.00M
Funding Rounds
Funding Rounds	6	4
Services
Services	Therapeutic Modulation of Alternative Splicing	Not tracked yet
Target Customers
Target Customers	Patients with Osteoarthritis, Cancer, Neurological Disorders, and Diabetes	Not tracked yet
Taxonomy
Taxonomy	Medical ResearchTherapeutics DevelopmentRegenerative MedicineOncologyDegenerative DiseasesAlternative Splicing +8	MRNA TherapeuticsVaccinesGene EditingProtein-based TherapyBiological ProgrammingNature-derived Medicines +7
Website
Website	biosplice.com	sendabiosciences.com

About Biosplice Therapeutics

Biosplice Therapeutics, founded in 2008 and headquartered in the United States, is dedicated to restoring health by delivering pioneering therapies that leverage alternative splicing. The company's focus on small-molecule therapeutics, rooted in the groundbreaking science of alternative pre-mRNA spl...

View Full Profile Alternatives

About Senda Biosciences

Senda Biosciences, founded in 2017 and headquartered in the United States, is carving a niche in the Biotechnology, Health Care, and Life Sciences sectors. The company's slogan, "Harnessing nature to program targeted, potent and tunable medicines," encapsulates their innovative approach. Senda is p...

View Full Profile Alternatives

Also comparing in this category

We will tell you when either one moves

BounceWatch watches Biosplice Therapeutics and Senda Biosciences for new funding, fast hiring, new executives and a change of software vendor. When one happens, it is in your next e-mail.

Get notified when Biosplice Therapeutics or Senda Biosciences moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Frequently Asked Questions

Biosplice Therapeutics was founded in 2008, based in San Diego, United States, with 37 employees. Biosplice Therapeutics, founded in 2008 and headquartered in the United States, is dedicated to restoring health by delivering pioneering therapies that leverage alternative splicing. The company's fo. Senda Biosciences was founded in 2017, based in Cambridge, United States, with 8 employees. Senda Biosciences, founded in 2017 and headquartered in the United States, is carving a niche in the Biotechnology, Health Care, and Life Sciences sectors. The company's slogan, "Harnessing nature to.

Biosplice Therapeutics has raised $778.00M and Senda Biosciences $266.00M. Latest stage: Biosplice Therapeutics Grant, Senda Biosciences Merged.

Both work in Biotechnology, Health Care and Life Sciences and list oncology among their focus areas.

Compare Biosplice Therapeutics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Biosplice Therapeutics on 24 Mar 2025, and Senda Biosciences on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.